Analyst Michael Ulz of Morgan Stanley maintained a Hold rating on Alnylam Pharma (ALNY – Research Report), retaining the price target of ...

B. “Alnylam’s (ALNY) commercial and clinical achievements in 2024 position us very well for another transformative year in 2025, as we continue to evolve into a global, top-tier biotech company,” said ...

One of the two North Korean soldiers captured by Ukraine has claimed during questioning that he thought he was going for training, not to the war against Ukraine, Kyiv's security s... The former head ...